Scilex Holding (SCLXW) Notes Payables (2020 - 2025)

Scilex Holding (SCLXW) recorded quarterly Notes Payables of $800000.0 in Q3 2025, down 95.92% quarter-over-quarter from $19.6 million in Q4 2021.

Scilex Holding (SCLXW) Notes Payables (2020 - 2025) Analysis & Trends

Scilex Holding's Notes Payables history runs 3 years deep, the most recent figure standing at $800000.0 for Q3 2025.

In Q3 2025, Notes Payables changed N/A year-over-year to $800000.0; the TTM figure through Sep 2025 stood at $800000.0 (changed N/A YoY), while the FY2021 annual figure was $19.6 million, up 15586.4% from the prior year.
Notes Payables was $800000.0 for Q3 2025 at Scilex Holding, down from $19.6 million in the prior quarter.
In the past five years, Notes Payables ranged from a high of $19.6 million in Q4 2021 to a low of $800000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn
10	Scilex Holding	-	-	4.15 Mn

Download Data